About serum beta2-microglobulin density and life prognostic connection

About serum beta2-microglobulin density and life prognostic connection - About serum beta2-microglobulin density and life prognostic connection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021281

Enrollment

Registered

2016-03-02

Start date

2016-03-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dialysis

Interventions

Change a dialysis condition to a hard condition Treat it by normal dialysis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Dialysis patient with more than regular 30 mg/L of serum beta 2 microglobulin density

Exclusion criteria

Exclusion criteria: Patient with cancer Patient with CRP where there is remarkable inflammation more than 2 The patient who uses blood catharsis except hemodialysis therapy or the hemodialysis filtration therapy together During the pregnancy or the patient whom I am nursing The patient who has a high disability in the liver, a heart, the lungs

Design outcomes

Primary

Measure	Time frame
1.The death rate 2.The number of the cardiovascular events 3.The number of the cerebrovascular events	—

Secondary

Measure	Time frame
1.Other clinical inspection level 2.Pain with the amyloid	—

Countries

Japan

Contacts

Public ContactYusaku Tanaka

Kawashima Hospital Clinical department of engineering

tanakayusaku0724@gmail.com088-631-0110

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026